MarketPulse

stock sale

19 articles
The Motley FoolThe Motley Fool··Jonathan Ponciano

Warrior Met Coal Insider Sale Signals Profit-Taking, Not Weakness

Warrior Met Coal insider sold $3.72M stake amid 263% EBITDA surge, signaling profit-taking after stock nearly doubled, not operational deterioration.
AERHCCearnings growthprofit-taking
The Motley FoolThe Motley Fool··Jonathan Ponciano

Fund Sells $4.7M in Bread Financial Despite Stock Surge, Strong Earnings

Brooktree Capital Management sold $4.68M in BFH shares amid 76.5% YoY surge. Sale appears routine despite strong Q1 earnings and improving metrics.
IBKRBFHBFHpARMNIearnings growthshare buyback
The Motley FoolThe Motley Fool··Robert Izquierdo

Adaptive Biotech COO Sells $271K in Stock, But Company's Growth Story Remains Intact

Adaptive Biotechnologies COO Julie Rubinstein sold 19,037 shares worth $271,000 under a pre-planned trading arrangement, retaining substantial equity as the biotech firm posts strong 55% revenue growth.
ADPToperating lossesrevenue growth
The Motley FoolThe Motley Fool··Jake Lerch

Conestoga Capital Dumps $45.7M in SPS Commerce Stock, Signals Confidence Retreat

Investment manager Conestoga Capital sold $45.7M of SPS Commerce shares in Q1 2026, nearly exiting position as stock plunges 59.8% annually.
RBCSPSCWCNvaluationAI investment
The Motley FoolThe Motley Fool··Howard Smith

TeraWulf Shares Tumble 6% on $900M Stock Sale as AI Data Center Operator Pursues Expansion

TeraWulf shares fell 6.21% after pricing a $900M stock offering at $19 per share, below the prior $20.95 close, raising dilution concerns as the AI data center operator expands infrastructure.
RIOTMARAWULFdata centerAI infrastructure
The Motley FoolThe Motley Fool··Robert Izquierdo

RingCentral CAO Sells $360K in Shares, but Pre-Planned Trade Signals No Major Concern

RingCentral's CAO sold $360K in shares via pre-planned trading agreement, retaining 75K+ shares, signaling no distress amid strong 2025 performance.
RNGvaluationprofitability
The Motley FoolThe Motley Fool··Jonathan Ponciano

HeartFlow CMO Sells $1.66M in Stock; Company Eyes Path to Profitability

HeartFlow CMO Rogers Campbell sold $1.66M in shares via pre-arranged plan while company guides 2026 revenue to $218–$222M, maintaining strong growth momentum despite current unprofitability.
HTFLrevenue growthinsider trading
The Motley FoolThe Motley Fool··Adé Hennis

Maze Therapeutics President Liquidates Full Position Ahead of Q4 Earnings

Maze Therapeutics president Harold Bernstein sold all 30,000 shares for $1.51M via pre-arranged trading plan, weeks before Q4 earnings report.
MAZEclinical-stage biotechearnings report
The Motley FoolThe Motley Fool··Will Healy

Fort Baker Exits TEGNA Stake Entirely, Dumps 1.68M Shares Worth $34.3M

Fort Baker Capital fully exits TEGNA stake, selling 1.68M shares worth $34.3M amid investor concerns over cord-cutting and traditional TV's structural decline.
WBDGOOGGOOGLTGNAfund exitstock sale
The Motley FoolThe Motley Fool··Jonathan Ponciano

Auto Parts Stock Soars 42%, but Major Investor Quietly Exits $6M Position

Advance Auto Parts surged 42% annually, but Beaconlight Capital sold its $6.24M stake, reducing holdings from 4.1% to 0.25% despite operational improvements.
TECKAAPportfolio rebalancingturnaround
The Motley FoolThe Motley Fool··Will Healy

Gilder Gagnon Howe Trims Duolingo Position by 15%, Cashing Out $15.7M

Investment firm Gilder Gagnon Howe sold 66,397 $DUOL shares worth $15.65M in Q4 2025, reducing stake by 15% amid broader software sector weakness.
NFLXNVDADUOLSHOPNETprofit-takingsoftware stocks
The Motley FoolThe Motley Fool··Robert Izquierdo

Owl Creek Dumps $40M Lyft Stake as Ridership Surges—A Red Flag for Investors?

Hedge fund Owl Creek sold 1.9M Lyft shares at peak valuations in Q4 2025. Stock has tumbled 30% in 2026 despite record operational metrics, signaling disconnect between execution and market expectations.
AMZNLYFTearnings missvaluation
BenzingaBenzinga··Chris Katje

Netflix Chair Hastings Dumps $39.8M Stock as Warner Bid Falls Through

Netflix Chairman Reed Hastings sold $39.8M in shares after the company abandoned its Warner Bros. Discovery acquisition bid, won by Paramount Skydance instead.
NFLXWBDacquisitionexecutive compensation
The Motley FoolThe Motley Fool··John Ballard

Meros Investment Trims Photronics Position After 74% Rally

Meros Investment Management sold 396,804 shares of Photronics in Q4 2025, cashing in $10 million in gains after stock surged 74.2% annually.
MGNIAMPLTHRDCOPLABvalue investingQ4 2025
BenzingaBenzinga··Chris Katje

Warner Bros. Discovery CEO Cashes Out $114M as Paramount Merger Eyes Q3 2026 Close

WBD CEO David Zaslav sold $114.1M in stock following strong 147.9% gains. Paramount-Skydance merger on track for Q3 2026 close, positioning him for billionaire status.
NFLXWBDmergermedia consolidation
The Motley FoolThe Motley Fool··Jake Lerch

Villanova Exits Air Lease Before Delisting: A Calculated Exit Strategy

Villanova Investment Management sold 66,230 Air Lease shares for $4.23M in February, exiting before the aircraft lessor's $65/share going-private deal concludes.
ALacquisitionportfolio rebalancing
The Motley FoolThe Motley Fool··Jake Lerch

Ancient Art L.P. Reduces Frontier Holdings Position by $3.1M in Q4 Filing

Ancient Art L.P. sold 700,000 Frontier Group shares worth $3.1M in Q4, reducing its stake while maintaining 3.82% ownership amid airline sector challenges.
ULCCIBKRstock declineturnaround strategy
The Motley FoolThe Motley Fool··Jonathan Ponciano

Commodore Capital Exits Majority Centessa Stake as Stock Rallies 53%

Commodore Capital exits majority Centessa stake, selling 1.85M shares for $46.86M amid 53% stock rally and company's strategic leadership changes.
CNTAbiotechclinical-stage
The Motley FoolThe Motley Fool··Jonathan Ponciano

Commodore Capital Cuts Nuvalent Position by $84M Despite Strong Stock Performance

Commodore Capital cuts $84M Nuvalent stake to 3.68% despite 29% stock gains. Biotech firm awaits September PDUFA decision for lead drug candidate.
RLAYNUVLFDA approvalclinical trials